| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/18/2007 | CA2615025A1 A method for detecting peptides comprising a cross-.beta. structure |
| 01/18/2007 | CA2614758A1 Promotion of epithelial regeneration |
| 01/18/2007 | CA2614754A1 Pharmaceutical compositions comprising a tgf-beta superfamily member |
| 01/18/2007 | CA2614680A1 Il-32 modulators |
| 01/18/2007 | CA2614678A1 Ligands of melanocortin receptors |
| 01/18/2007 | CA2614619A1 Formulations for enhanced mucosal delivery of pyy |
| 01/18/2007 | CA2614480A1 Chaperonin 10-induced immunomodulation |
| 01/18/2007 | CA2614436A1 Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus |
| 01/18/2007 | CA2613976A1 New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 01/18/2007 | CA2609597A1 Method for evaluating the effects of smoke on bronchioles |
| 01/18/2007 | CA2602452A1 Cyclosporin compositions |
| 01/17/2007 | EP1743945A1 Screening method |
| 01/17/2007 | EP1743940A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/17/2007 | EP1743903A2 Methods and compositions for treating disorders involving excitotoxicity |
| 01/17/2007 | EP1743883A1 Use of biphenyl-derived thiamides as calpain inhibitors |
| 01/17/2007 | EP1743653A1 Composition for increasing body height |
| 01/17/2007 | EP1743650A2 Feline intrerferon against feline atopic dermatitis |
| 01/17/2007 | EP1743649A1 Treatment and diagnosis of infertility using TGF beta or activin |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1742971A2 N-acylated chitinous polymers and methods of use thereof |
| 01/17/2007 | EP1742968A2 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 01/17/2007 | EP1742964A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation |
| 01/17/2007 | EP1742961A2 Inhibition of fgf signaling |
| 01/17/2007 | EP1742913A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/17/2007 | EP1742663A2 Compositions capable of facilitating penetration across a biological barrier |
| 01/17/2007 | EP1742655A2 Use of ghrelin for the treatment of hyperthyroidism |
| 01/17/2007 | EP1742654A2 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 01/17/2007 | EP1742653A2 Ammonium/ammonia transporter |
| 01/17/2007 | EP1742652A2 Use of cyclosporins for treatment of cerebral ischemia and brain and spinal cord injury |
| 01/17/2007 | EP1742651A2 Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment |
| 01/17/2007 | EP1742650A1 Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors |
| 01/17/2007 | EP1453852B1 Selective urokinase inhibitors |
| 01/17/2007 | EP1450852B1 Ptp10d nucleic acids and peptides involved in the regulation of energy homeostasis |
| 01/17/2007 | EP1450762B1 Novel formulation |
| 01/17/2007 | EP1399480B1 Multimers of class i major histocompatibility complexes containing modified beta2-microglobulin proteins |
| 01/17/2007 | EP1370259B1 Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder |
| 01/17/2007 | EP1368474B1 Polynucleotide useful for modulating cancer cell proliferation |
| 01/17/2007 | EP1345501B1 Nutritional and therapeutical preparations having antioxidant activity |
| 01/17/2007 | EP1341531B1 Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 01/17/2007 | EP1322411B1 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 01/17/2007 | EP1283047B1 Method for producing a bioactive substance from blood serum |
| 01/17/2007 | EP1272160B1 Lipid-based drug delivery systems for topical application |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1263783B1 Maurocalcine, analogues thereof and their therapeutical uses |
| 01/17/2007 | EP1244388B1 Intervertebral disc treatment device |
| 01/17/2007 | EP1223977B1 Modified plant viruses and methods of use thereof |
| 01/17/2007 | EP1179539B1 Protein having hemolytic activity and gene encoding the protein |
| 01/17/2007 | EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 01/17/2007 | EP1131430B1 Mitogenic regulators |
| 01/17/2007 | EP1087996B1 Glycosulfopeptides and methods of synthesis and use thereof |
| 01/17/2007 | EP1076704B1 Il-2 selective agonists and antagonists |
| 01/17/2007 | EP0986312B1 Method for treating a lactic raw material containing gmp |
| 01/17/2007 | EP0954588B1 Ob fusion protein compositions and methods |
| 01/17/2007 | EP0220273B2 Synthetic antigens for the detection of aids-related disease |
| 01/17/2007 | CN1898385A Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 01/17/2007 | CN1898262A Il-7 fusion proteins |
| 01/17/2007 | CN1898261A Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 01/17/2007 | CN1898260A Peptides with anti-obesity activity and other related uses |
| 01/17/2007 | CN1898257A Methods for synthesis of encoded libraries |
| 01/17/2007 | CN1898219A Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 01/17/2007 | CN1897973A Propagation agent and propagation method for natural killer cell |
| 01/17/2007 | CN1897969A Selective incorporation of 5-hyroxytrypophan into proteins in mammalian cells |
| 01/17/2007 | CN1897968A Method of treatment using interferon-tau |
| 01/17/2007 | CN1897967A A pharmaceutical composition comprising an active principle and sulphobetaine |
| 01/17/2007 | CN1897966A Therapeutic regimens for baff antagonists |
| 01/17/2007 | CN1897965A Method of treating or preventing biological or immunological responses to a reactive chemical or biological or toxic agent |
| 01/17/2007 | CN1897964A A composition for cartilage therapeutics and using method thereof |
| 01/17/2007 | CN1897963A Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof |
| 01/17/2007 | CN1897962A Glycopegylated erythropoietin |
| 01/17/2007 | CN1897961A Methods and compositions for the prevention and treatment of inflammatory diseases or conditions |
| 01/17/2007 | CN1897960A Tissue protective cytokines for protection, restoration, and enhancement of responsive cells, tissues and organs with extended therapeutic window |
| 01/17/2007 | CN1897959A Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions |
| 01/17/2007 | CN1897957A Chaperone-based therapy for niemann-pick disease |
| 01/17/2007 | CN1897951A Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 01/17/2007 | CN1897922A Process for producing pellets for pharmaceutical compositions |
| 01/17/2007 | CN1897828A Health food, process for producing the same and dried matter or extract |
| 01/17/2007 | CN1896270A Therapeutic and preventing methods for bone loss |
| 01/17/2007 | CN1896238A Genic engineering strain of expression recombinant prawn peptide Pen24 and its use |
| 01/17/2007 | CN1896236A Sodium-channel modulator Bmk a IV gene and its clonal and recombinant-protein expression |
| 01/17/2007 | CN1896232A Ginkgo endogenous fusanin plasminogen, its production and use |
| 01/17/2007 | CN1896231A Method for separating tetramer uric acid oxydiazing enzyme |
| 01/17/2007 | CN1896108A Preparation of specific anticoagulation matter and its use |
| 01/17/2007 | CN1896107A Cecropin A-magainin hybrid gene engineering bactericidal peptide |
| 01/17/2007 | CN1896104A Fused protein for cell inhibitory factor and albumin |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896100A Liver regenerated factor and its use |
| 01/17/2007 | CN1896099A Zinc finger binding domains for gnn |
| 01/17/2007 | CN1896098A Buthotoxin polypeptide and its use |
| 01/17/2007 | CN1896097A Peptide for promoting insulin release of frog and its use in production of drugs |
| 01/17/2007 | CN1896096A Production of high-activity extrasin beta 4 derivative by gene engineering |
| 01/17/2007 | CN1896095A Lucid ganoderma sugar peptide, its production and use |
| 01/17/2007 | CN1896094A Angiotensin II receptors I immunogenic peptide section and its use |
| 01/17/2007 | CN1895671A Compound preparation for treating viral liver disease |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1895665A Scorpionfish-ink polysaccharide and its preparation |
| 01/17/2007 | CN1895664A Cordyceps sinensis and emu collagens peptide capsules and production thereof |
| 01/17/2007 | CN1895663A Repairing paste of emu oil and its proudction |
| 01/17/2007 | CN1895662A Use of kerato cell growth factor-2 in treatment of chronic cervicitis medicine |
| 01/17/2007 | CN1895661A Preparation of cotton-seed polypeptide with anti-oxidant function |
| 01/17/2007 | CN1895660A Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |